Objective: To perform molecular diagnosis and genetic counseling in a young Chinese couple with congenital hearing loss. Methods: Variant screening analysis was performed by PCR and direct Sanger sequencing or targeted next-generation sequencing of all known hearing loss genes. Novel variants were evaluated by PolyPhen2 and PROVEAN software tools to evaluate possible effects on protein function.
Introduction
Hearing loss (HL) is the most frequent sensory deficit in humans, with a prevalence of around 1/1000 in newborns. 1, 2 Approximately 50% to 60% of hearing loss cases are caused by genetic factors. 3 The genetic mode of HL inheritance can be autosomal recessive, autosomal dominant, mitochondrial, or X/Y-linked. To date, 121 genes have been reported to be associated with hearing loss (http://heredi taryhearingloss.org/): 45 are autosomal dominant genes,71 are autosomal recessive, and 5 are X-linked. However, most of these genes have only been reported in one or a few families. 4 Epidemiological studies showed that variants in GJB2, SLC26A4, and 12S rRNA genes are highly correlated with hereditary HL. 2 The most frequent genetic cause of HL is variants in GJB2, and most of these cases occur with nonprogressive HL. Variants in SLC26A4, CDH23, and MYO3A were also shown to be associated with naturally occurring progressive HL. 5, 6 The genetic diagnosis of HL is very important because the findings can be used to aid treatment decisions, and provide prognostic information and genetic counseling for the patient's family. 7 Here, we describe a young couple with HL in whom the husband carried compound heterozygous variants of GJB2, and the wife had an extremely rare form of deafness and compound heterozygous variants of LOXHD1. We provided genetic counseling for this couple and followed them up during their pregnancy.
Patients and methods

Study population
We recruited a young Chinese couple (husband: 27 years old; wife: 25 years old) with congenital HL and 100 healthy controls (aged 25-30 years) from Gansu Provincial Maternal and Child Health Care Hospital. The couple had been married for 6 months and requested pre-pregnancy genetic counseling. The study was in accordance with the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of Gansu Provincial Maternal and Child Health Care Hospital. Written informed consent was obtained from all participants.
Sample collection and genomic DNA preparation
Blood samples (2-3 mL) were collected from the probands and their parents and control individuals. Genomic DNA was extracted using a Tiangen DNA extraction kit (Tiangen Biotech, Beijing, China) according to the manufacturer's instructions and quantified spectrophotometrically.
Targeted next-generation sequencing (NGS) and Sanger sequencing
First, the coding exon and flanking sequences of GJB2 were screened by PCR and direct sequencing using primers and conditions described in Table 1 . If no GJB2 variant was found, targeted capture of candidate disease genes (n ¼ 165, Table 2 ) was performed using a GenCap custom 
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Bioinformatics analysis
If a novel variant was found that was not reported in the Human Gene Variant Database (http://www.hgmd.cf.ac.uk/) or ClinVar database (https://www.ncbi.nlm. nih.gov/clinvar/), we used PolyPhen2 (http://genetics.bwh.harvard.edu/pph2) and PROVEAN (http://provean.jcvi.org/index. php) tools to predict its possible functional role. To exclude the possibility that the variant was a polymorphism, we also performed direct sequencing in 100 healthy controls.
Results
Variant analysis
PCR and direct Sanger sequencing identified c.235delC (rs80338943)/c.299-300delAT (rs111033204) compound heterozygous variants of GJB2 in the husband. c.235delC was inherited from his mother and c.299-300delAT was inherited from his father (Figure 1) .
No GJB2 variants were identified in the wife, so targeted NGS was used to search for potential pathogenic variants. She was shown to carry c.1828G>A (p.Glu610Lys, rs535637788)/c.2825-2827delAGA compound heterozygous variants of LOXHD1, with c.2825-2827delAGA inherited from her mother and c.1828G>A from her father ( Figure 2 ). Her hearing loss is an extremely rare form known as DFNB77 (OMIM: 613079). Variant c.2825-2827delAGA has previously been reported to be associated with DFNB77, 7 but variant c.1828G>A (p.E610K) was only reported in a Mexican-American individual in the 1000 Genomes database. It has not been reported to be associated with DFNB77. PCR and direct Sanger sequencing did not identify this variant in any of our 100 healthy controls.
Bioinformatics analysis score
PolyPhen2 and PROVEAN tools were used to evaluate the possible functional role of variant c.1828G>A. PolyPhen2 gave a score of 1, suggesting that the site might be a damaging variation. The PROVEAN score was -3.203, and the site was considered "deleterious".
Pregnancy outcome
Following molecular analysis, we provided genetic counseling to the young couple with HL. We explained that their children were unlikely to have HL because they both carried different genetic variants. During their pregnancy, they underwent regular prenatal (Figures 1 and 2) . The baby was born in June 2018, and both ears passed the hearing screening test.
Discussion
We identified causative variants of HL in both individuals of a young Chinese couple. The variants of the husband were common and the c.2825-2827delAGA LOXHD1 variant of the wife was previously associated with DFNB77; however, the c.1828G>A LOXHD1 variant of the wife has only been reported in a Mexican-American individual in the 1000 Genomes database, and not in the HGMD database or elsewhere. PolyPhen2 and PROVEAN tools suggested that it is a likely pathogenic variant.
LOXHD1 is located on chromosome 18q12-q21 and contains at least 43 exons. 8 It encodes lipoxygenase homology domain 1-containing protein 1 which has 15 PLAT domains 4 that are involved in targeting proteins to the plasma membrane and mediating protein interactions. [9] [10] [11] [12] Mouse studies showed that the Loxhd1 product is localized to the stereocilia of sensory hair cells, and that Loxhd1 variants can induce deafness with defects in the stereocilia followed by hair cell degeneration. 13 This indicates that LOXHD1 plays an important role in maintaining normal hair cell function.
Although DFNB77 has previously been associated with LOXHD1 variants, it is a highly heterogeneous disease both phenotypically and genetically. More than 23 probands with DFNB77 have been reported worldwide on PubMed, and 37 different disease-causing variants have been identified (Table 3) . 5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Most of these probands come from Asia, suggesting that it has a high incidence of DFNB77. They show different auditory characteristics and audiometric phenotypes, varying from mild to profound and from stable to progressive sensorineural HL. 5,7-21 Animal 13 However, Wesdorp et al. 4 found that the type of variant (nonsense or missense) did not associate with HL severity, and that the combination of a nonsense and missense variant could cause different audiometric phenotypes. Such research is limited, so correlations between LOXHD1 variants and phenotypic characteristics of HL remain unclear. LOXHD1 variants have not only been linked to HL but are also associated with late-onset Fuchs corneal dystrophy (FCD), a genetic disorder of the corneal endothelium. 22 A case-control study by Stehouwer et al. 23 reported a significant association between FCD and hearing disorders, but this should be investigated in larger sample sizes. 22 We believe that it is important to check for ophthalmology disorders in patients with HL caused by LOXHD1 variants; however, we found no FCD phenotype in the current proband with LOXHD1 variants.
In conclusion, we carried out molecular diagnosis in a young couple with congenital HL and identified different disease-causing variants in the two individuals. The husband had compound heterozygous variants of GJB2, while the wife had the extremely rare HL known as DFNB77 and compound heterozygous variants of LOXHD1. We followed up the pregnancy outcome of this couple, and report that both ears of their baby passed the hearing screening test. To the best of our knowledge, this is the third case reported in Chinese individuals and the first in the northwest of the country. PCR and direct Sanger sequencing cannot provide effective detection of diseases caused by such rare variants. However, with the development of molecular diagnostic technology, the cost of tests is decreasing and NGS will become a more effective way of providing accurate molecular diagnosis and genetic counseling for rare diseases.
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